Trial intelligence / Profile preview

Tolerability of primaquine radical cure regimen in G6PD-deficient healthy volunteers in Thailand

TCTR20170830002Phase 2Completed

Sponsor
University of Oxford
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of primaquine in vivax malaria, sponsored by University of Oxford. Started Nov 2018; status: completed.

02

Drugs

primaquine
03

Conditions

vivax malaria

Beyond the preview

Go deeper on TCTR20170830002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170830002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call